» Articles » PMID: 27033291

Hepatosplenic T-cell Lymphoma in a Young Immunocompetent Man

Overview
Journal BMJ Case Rep
Specialty General Medicine
Date 2016 Apr 2
PMID 27033291
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatosplenic T-cell lymphoma (HSTCL) is a rare, aggressive type of peripheral T-cell lymphoma that is characterised by extranodal disease, with infiltration and proliferation of malignant T-cells within the liver, spleen and bone marrow. The authors report the case of a young immunocompetent man, who was admitted to the hospital with a history of prolonged, unexplained fever, fatigue and weight loss. Initial blood work showed mild pancytopaenia and imaging studies revealed hepatosplenomegaly. The diagnosis was challenging, initially mimicking infectious disease, and it required an extensive investigation that ultimately revealed the characteristic clinical, histopathological and cytogenetic features of HSTCL. The clinical course was aggressive, and despite multiagent chemotherapy, the patient died 4 months after the diagnosis. This case highlights the difficulty of diagnosing HSTCL and the importance of considering it in a differential diagnosis of hepatosplenomegaly in young men who present with constitutional symptoms and no lymphadenopathy.

Citing Articles

Clinical and splenectomy-based treatment outcomes in 40 cases of hepatosplenic T-cell lymphoma: a comprehensive analysis.

Mingyue-Chen , Wu M, Yanhui-Xie , Shen L World J Surg Oncol. 2024; 22(1):330.

PMID: 39696449 PMC: 11656711. DOI: 10.1186/s12957-024-03613-0.


Decoding the diagnostic dilemma: Peripheral T‑cell lymphoma presenting as acute pancreatitis: A case report.

Vikash F, Vikash S, Mehta A, Nagraj S, Patel S, Ho S Oncol Lett. 2024; 27(2):73.

PMID: 38192680 PMC: 10773221. DOI: 10.3892/ol.2023.14206.


Hepatosplenic T-Cell Lymphoma in an Immunocompetent Young Male: A Challenging Diagnosis.

Ammad Ud Din M, Sham R, Hussain S, Shapiro J Cureus. 2020; 12(7):e8993.

PMID: 32775075 PMC: 7402550. DOI: 10.7759/cureus.8993.

References
1.
Voss M, Lunning M, Maragulia J, Papadopoulos E, Goldberg J, Zelenetz A . Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience. Clin Lymphoma Myeloma Leuk. 2012; 13(1):8-14. PMC: 4056251. DOI: 10.1016/j.clml.2012.09.002. View

2.
Ross C, Schnitzer B, Sheldon S, Braun D, Hanson C . Gamma/delta T-cell posttransplantation lymphoproliferative disorder primarily in the spleen. Am J Clin Pathol. 1994; 102(3):310-5. DOI: 10.1093/ajcp/102.3.310. View

3.
Benjamini O, Jain P, Konoplev S, Yin C, Abruzzo L, Wotherspoon A . CD4(-)/CD8(-) variant of T-cell large granular lymphocytic leukemia or hepatosplenic T-cell lymphoma: a clinicopathologic dilemma. Clin Lymphoma Myeloma Leuk. 2013; 13(5):610-3. PMC: 4167023. DOI: 10.1016/j.clml.2013.04.010. View

4.
Belhadj K, Reyes F, Farcet J, Tilly H, Bastard C, Angonin R . Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood. 2003; 102(13):4261-9. DOI: 10.1182/blood-2003-05-1675. View

5.
Nosari A, Oreste P, Biondi A, Costantini M, Santoleri L, Intropido L . Hepato-splenic gammadelta T-cell lymphoma: a rare entity mimicking the hemophagocytic syndrome. Am J Hematol. 1999; 60(1):61-5. DOI: 10.1002/(sici)1096-8652(199901)60:1<61::aid-ajh10>3.0.co;2-l. View